Ontario Removes OxyContin from List

.

Ontario Removes OxyContin from List

As per a recent report, the drug OxyContin, which is highly prescribed for being known as a painkiller, is being removed by Ontario from the list of its drug benefit program. It is being done since the drug overdose causes several numbers of deaths each year in the province.

It has been announced on Friday that the drug would be delisted from the program as it has become an addiction epidemic in the province. The so called hillbilly heroin is suggested by physicians at a large pace and its addictive attributes led people to take its extra doses.

The report says that the province has taken the decision of delisting not only OxyContin but its substitute too. The Health Minister, Deb Matthews, has affirmed that the problem of drug abuse and its large prescription by doctors is being taken seriously, aiming to cut the use of the drug that could further reduce number of deaths of people.

However, it is not for the first time that a drug has been delisted because of safety concerns, says the report. But, the removal of the drug for its abuse and addiction has happened for the first time. It is being said that the change introduced in the system would most possibly help in making it hard for physicians to prescribe the same.

As per the addictions specialists and physicians who treat chronic pain with the drug, the new strategies would encourage physicians to confirm benefits and risks of the drug first and then prescribe it. “Over time, what we will likely see is a reduction in the number of people who are prescribed OxyContin and as a consequence hopefully see fewer people becoming addicted . . . and a fewer people dying of OxyContin overdoses”, said Dr. Irfan Dhalla, a physician and scientist at St. Michael’s Hospital.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves